Analyze Diet
International journal of cancer2017; 141(2); 342-353; doi: 10.1002/ijc.30744

A missense mutation in damage-specific DNA binding protein 2 is a genetic risk factor for limbal squamous cell carcinoma in horses.

Abstract: Squamous cell carcinoma (SCC) is the most common cancer of the equine eye, frequently originating at the limbus, with the potential to invade the cornea, cause visual impairment, and result in loss of the eye. Several breeds of horses have a high occurrence of limbal SCC implicating a genetic basis for limbal SCC predisposition. Pedigree analysis in the Haflinger breed supports a simple recessive mode of inheritance and a genome-wide association study (N = 23) identified a 1.5 Mb locus on ECA12 significantly associated with limbal SCC (Pcorrected = 0.04). Sequencing the most physiologically relevant gene from this locus, damage specific DNA binding protein 2 (DDB2), identified a missense mutation (c.1013 C > T p.Thr338Met) that was strongly associated with limbal SCC (P = 3.41 × 10-10 ). Genotyping 42 polymorphisms narrowed the ECA12 candidate interval to 483 kb but did not identify another variant that was more strongly associated. DDB2 binds to ultraviolet light damaged DNA and recruits other proteins to perform global genome nucleotide excision repair. Computational modeling predicts this mutation to be deleterious by altering conformation of the β loop involved in photolesion recognition. This DDB2 variant was also detected in two other closely related breeds with reported cases of ocular SCC, the Belgian and the Percheron, suggesting it may also be a SCC risk factor in these breeds. Furthermore, in humans xeroderma pigmentosum complementation group E, a disease characterized by sun sensitivity and increased risk of cutaneous SCC and melanomas, is explained by mutations in DDB2. Cross-species comparison remains to be further evaluated.
Publication Date: 2017-05-08 PubMed ID: 28425625DOI: 10.1002/ijc.30744Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research identifies a specific genetic missense mutation in horses that increases the risk of developing squamous cell carcinoma (SCC), a common equine eye cancer. It furthers the understanding of the genetic factors underlying SCC predisposition in certain horse breeds.

Context and Aim of the Research

  • This research paper is situated within the field of veterinary genetics, specifically studying genetic factors related to equine eye cancers.
  • The primary aim of the research was to identify potential genetic risk factors for limbal squamous cell carcinoma (SCC) — a common eye cancer in horses that starts in the limbus and can invade the cornea, impair vision, or cause loss of the eye.
  • Given the high occurrence of limbal SCC in certain horse breeds, the researchers aimed to explore a genetic basis of susceptibility to this disease.

Methods

  • A breed of horse, the Haflinger, with a high occurrence of limbal SCC, was analyzed genetically, revealing what the researchers describe as a simple recessive mode of inheritance.
  • A genome-wide association study then identified a potential locus on a chromosome (ECA12) involved in this cancer’s occurrence.
  • The researchers sequenced the most relevant gene from this identified locus, the Damage Specific DNA Binding Protein 2 (DDB2), and identified a missense mutation.
  • The researchers used computer modeling to predict the mutation’s impact on recognising photolesion damages in DNA.

Findings

  • The sequencing of DDB2 identified a missense mutation (c.1013 C > T p.Thr338Met) that showed a strong association with limbal SCC.
  • Computational modeling predicted the mutation to be deleterious, likely altering the conformation of the β loop involved in photolesion recognition.
  • The same DDB2 variant was found in two other horse breeds with reported cases of ocular SCC – Belgian and Percheron, suggesting their potential genetic predisposition to SCC.
  • This finding aligns with existing knowledge about a human disease called xeroderma pigmentosum complementation group E, characterized by sun sensitivity and higher risk for skin SCC and melanomas, which also links to mutations in DDB2.

Implications

  • The research demonstrates the SCC association with the identified DDB2 variant across multiple horse breeds which could aid in the development of future genetic testing strategies to detect at-risk animals.
  • The findings also underline the importance of cross-species comparison in studying diseases and drawing parallels between human and animal disease mechanisms.

Cite This Article

APA
Bellone RR, Liu J, Petersen JL, Mack M, Singer-Berk M, Drögemüller C, Malvick J, Wallner B, Brem G, Penedo MC, Lassaline M. (2017). A missense mutation in damage-specific DNA binding protein 2 is a genetic risk factor for limbal squamous cell carcinoma in horses. Int J Cancer, 141(2), 342-353. https://doi.org/10.1002/ijc.30744

Publication

ISSN: 1097-0215
NlmUniqueID: 0042124
Country: United States
Language: English
Volume: 141
Issue: 2
Pages: 342-353

Researcher Affiliations

Bellone, Rebecca R
  • Veterinary Genetics Laboratory, School of Veterinary Medicine, University of California-Davis, Davis, CA.
  • Department of Population Health and Reproduction, School of Veterinary Medicine, University of California-Davis, Davis, CA.
Liu, Jiayin
  • Veterinary Genetics Laboratory, School of Veterinary Medicine, University of California-Davis, Davis, CA.
  • Department of Population Health and Reproduction, School of Veterinary Medicine, University of California-Davis, Davis, CA.
Petersen, Jessica L
  • Department of Animal Science, University of Nebraska - Lincoln, Lincoln, NE.
Mack, Maura
  • Veterinary Genetics Laboratory, School of Veterinary Medicine, University of California-Davis, Davis, CA.
  • Department of Population Health and Reproduction, School of Veterinary Medicine, University of California-Davis, Davis, CA.
Singer-Berk, Moriel
  • Veterinary Genetics Laboratory, School of Veterinary Medicine, University of California-Davis, Davis, CA.
  • Department of Population Health and Reproduction, School of Veterinary Medicine, University of California-Davis, Davis, CA.
Drögemüller, Cord
  • Institute for Genetics University of Bern, Bern, Switzerland.
Malvick, Julia
  • Veterinary Genetics Laboratory, School of Veterinary Medicine, University of California-Davis, Davis, CA.
Wallner, Barbara
  • Department of Biomedical Sciences, University of Veterinary Medicine Vienna, Institute of Animal Breeding and Genetics, Vienna, Austria.
Brem, Gottfried
  • Department of Biomedical Sciences, University of Veterinary Medicine Vienna, Institute of Animal Breeding and Genetics, Vienna, Austria.
Penedo, M Cecilia
  • Veterinary Genetics Laboratory, School of Veterinary Medicine, University of California-Davis, Davis, CA.
Lassaline, Mary
  • Department of Surgical & Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, CA.

MeSH Terms

  • Animals
  • Carcinoma, Squamous Cell / genetics
  • Carcinoma, Squamous Cell / veterinary
  • Computational Biology
  • DNA Damage
  • DNA-Binding Proteins / chemistry
  • DNA-Binding Proteins / genetics
  • Eye Neoplasms / genetics
  • Eye Neoplasms / veterinary
  • Female
  • Genetic Predisposition to Disease
  • Genome-Wide Association Study / veterinary
  • Horse Diseases / genetics
  • Horses
  • Limbus Corneae / pathology
  • Male
  • Mutation, Missense
  • Pedigree
  • Protein Structure, Secondary
  • Sequence Analysis, DNA / veterinary

Citations

This article has been cited 20 times.
  1. Schwarz S, Kummer S, Klang A, Walter I, Nell B, Brandt S. Detection of vasculogenic mimicry in equine ocular, oronasal, and genital squamous cell carcinoma. PLoS One 2026;21(1):e0328584.
    doi: 10.1371/journal.pone.0328584pubmed: 41490689google scholar: lookup
  2. Kingsley NB, Sandmeyer L, Dwyer A, Langefeld CD, McMullen RJ Jr, McCue M, Lassaline M, Bellone RR. A genome-wide investigation of insidious uveitis in Appaloosa horses. BMC Genomics 2025 Oct 9;26(1):904.
    doi: 10.1186/s12864-025-12099-3pubmed: 41068571google scholar: lookup
  3. Quatember H, Nell B, Richter B, Rigler D, Dolezal M, Sykora S, Wallner B. Studying the Impact of the DDB2 T338M Missense Mutation on the Development of Equine Squamous Cell Carcinoma and Sarcoid. Animals (Basel) 2025 Mar 22;15(7).
    doi: 10.3390/ani15070911pubmed: 40218305google scholar: lookup
  4. Ing ST, Pinard CL, James-Jenks EM, Leis ML. A retrospective survey of equine ocular diseases evaluated at a referral hospital in Ontario (2011 to 2021). Can Vet J 2025 Mar;66(3):308-317.
    pubmed: 40070935
  5. Chow L, Flaherty E, Pezzanite L, Williams M, Dow S, Wotman K. Impact of Equine Ocular Surface Squamous Neoplasia on Interactions between Ocular Transcriptome and Microbiome. Vet Sci 2024 Apr 7;11(4).
    doi: 10.3390/vetsci11040167pubmed: 38668434google scholar: lookup
  6. Martabano BB, Dow S, Chow L, Williams MMV, Mack MK, Bellone R, Wotman KL. Intralesional interferon alpha-2b as a novel treatment for periocular squamous cell carcinoma in horses. PLoS One 2024;19(2):e0297366.
    doi: 10.1371/journal.pone.0297366pubmed: 38381740google scholar: lookup
  7. Miglinci L, Reicher P, Nell B, Koch M, Jindra C, Brandt S. Detection of Equine Papillomaviruses and Gamma-Herpesviruses in Equine Squamous Cell Carcinoma. Pathogens 2023 Jan 23;12(2).
    doi: 10.3390/pathogens12020179pubmed: 36839451google scholar: lookup
  8. Wotman KL, Chow L, Martabano B, Pezzanite LM, Dow S. Novel ocular immunotherapy induces tumor regression in an equine model of ocular surface squamous neoplasia. Cancer Immunol Immunother 2023 May;72(5):1185-1198.
    doi: 10.1007/s00262-022-03321-2pubmed: 36367558google scholar: lookup
  9. Criscione A, Mastrangelo S, D'Alessandro E, Tumino S, Di Gerlando R, Zumbo A, Marletta D, Bordonaro S. Genome-wide survey on three local horse populations with a focus on runs of homozygosity pattern. J Anim Breed Genet 2022 Sep;139(5):540-555.
    doi: 10.1111/jbg.12680pubmed: 35445758google scholar: lookup
  10. Durward-Akhurst SA, Schaefer RJ, Grantham B, Carey WK, Mickelson JR, McCue ME. Genetic Variation and the Distribution of Variant Types in the Horse. Front Genet 2021;12:758366.
    doi: 10.3389/fgene.2021.758366pubmed: 34925451google scholar: lookup
  11. Crausaz M, Launois T, Smith-Fleming K, McCoy AM, Knickelbein KE, Bellone RR. DDB2 Genetic Risk Factor for Ocular Squamous Cell Carcinoma Identified in Three Additional Horse Breeds. Genes (Basel) 2020 Dec 5;11(12).
    doi: 10.3390/genes11121460pubmed: 33291392google scholar: lookup
  12. Chen L, Bellone RR, Wang Y, Singer-Berk M, Sugasawa K, Ford JM, Artandi SE. A novel DDB2 mutation causes defective recognition of UV-induced DNA damages and prevalent equine squamous cell carcinoma. DNA Repair (Amst) 2021 Jan;97:103022.
    doi: 10.1016/j.dnarep.2020.103022pubmed: 33276309google scholar: lookup
  13. Hisey EA, Hermans H, Lounsberry ZT, Avila F, Grahn RA, Knickelbein KE, Duward-Akhurst SA, McCue ME, Kalbfleisch TS, Lassaline ME, Back W, Bellone RR. Whole genome sequencing identified a 16 kilobase deletion on ECA13 associated with distichiasis in Friesian horses. BMC Genomics 2020 Nov 30;21(1):848.
    doi: 10.1186/s12864-020-07265-8pubmed: 33256610google scholar: lookup
  14. Levitt S, Osinchuk S, Sandmeyer L. Diagnostic Ophthalmology. Can Vet J 2020 Jul;61(7):789-791.
    pubmed: 32655166
  15. Singer-Berk MH, Knickelbein KE, Lounsberry ZT, Crausaz M, Vig S, Joshi N, Britton M, Settles ML, Reilly CM, Bentley E, Nunnery C, Dwyer A, Lassaline ME, Bellone RR. Additional Evidence for DDB2 T338M as a Genetic Risk Factor for Ocular Squamous Cell Carcinoma in Horses. Int J Genomics 2019;2019:3610965.
    doi: 10.1155/2019/3610965pubmed: 31637255google scholar: lookup
  16. Tanaka J, Leeb T, Rushton J, Famula TR, Mack M, Jagannathan V, Flury C, Bachmann I, Eberth J, McDonnell SM, Penedo MCT, Bellone RR. Frameshift Variant in MFSD12 Explains the Mushroom Coat Color Dilution in Shetland Ponies. Genes (Basel) 2019 Oct 19;10(10).
    doi: 10.3390/genes10100826pubmed: 31635058google scholar: lookup
  17. Raudsepp T, Finno CJ, Bellone RR, Petersen JL. Ten years of the horse reference genome: insights into equine biology, domestication and population dynamics in the post-genome era. Anim Genet 2019 Dec;50(6):569-597.
    doi: 10.1111/age.12857pubmed: 31568563google scholar: lookup
  18. Grilz-Seger G, Neuditschko M, Ricard A, Velie B, Lindgren G, Mesarič M, Cotman M, Horna M, Dobretsberger M, Brem G, Druml T. Genome-Wide Homozygosity Patterns and Evidence for Selection in a Set of European and Near Eastern Horse Breeds. Genes (Basel) 2019 Jun 28;10(7).
    doi: 10.3390/genes10070491pubmed: 31261764google scholar: lookup
  19. Jeanes EC, Koll-Hampp S, Dawson C, Dunkel B, Tetas Pont R. Rhomboid blepharoplasty and cryotherapy for the treatment of a squamous cell carcinoma on the lower eyelid in a horse. Clin Case Rep 2019 Jan;7(1):40-46.
    doi: 10.1002/ccr3.1907pubmed: 30656005google scholar: lookup
  20. Kalbfleisch TS, Rice ES, DePriest MS Jr, Walenz BP, Hestand MS, Vermeesch JR, O Connell BL, Fiddes IT, Vershinina AO, Saremi NF, Petersen JL, Finno CJ, Bellone RR, McCue ME, Brooks SA, Bailey E, Orlando L, Green RE, Miller DC, Antczak DF, MacLeod JN. Improved reference genome for the domestic horse increases assembly contiguity and composition. Commun Biol 2018;1:197.
    doi: 10.1038/s42003-018-0199-zpubmed: 30456315google scholar: lookup